.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Harvard Business School
Healthtrust
AstraZeneca
Farmers Insurance
Baxter
Daiichi Sankyo
Accenture
Medtronic

Generated: June 26, 2017

DrugPatentWatch Database Preview

Gemfibrozil - Generic Drug Details

« Back to Dashboard

What are the generic sources for gemfibrozil and what is the scope of gemfibrozil freedom to operate?

Gemfibrozil
is the generic ingredient in two branded drugs marketed by Impax Pharms, Caribe Holdings, Sandoz, Pfizer Pharms, Aurobindo Pharma Ltd, Purepac Pharm, Apotex, Invagen Pharms, Sun Pharm Inds Inc, Watson Labs, Mylan, Teva, Cadila Pharms Ltd, Chartwell Molecules, Northstar Hlthcare, and Hikma Pharms, and is included in nineteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for gemfibrozil. Forty-nine suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: gemfibrozil

Tradenames:2
Patents:1
Applicants:16
NDAs:19
Drug Master File Entries: see list20
Suppliers / Packagers: see list49
Bulk Api Vendors: see list69
Clinical Trials: see list32
Patent Applications: see list5,600
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:gemfibrozil at DailyMed

Pharmacology for Ingredient: gemfibrozil

Tentative approvals for GEMFIBROZIL

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe300MGCAPSULE;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc
GEMFIBROZIL
gemfibrozil
TABLET;ORAL079239-001Dec 29, 2008ABRXNoNo► Subscribe► Subscribe
Sandoz
GEMFIBROZIL
gemfibrozil
TABLET;ORAL074615-001Sep 29, 1995DISCNNoNo► Subscribe► Subscribe
Impax Pharms
GEMFIBROZIL
gemfibrozil
TABLET;ORAL078207-001Jun 1, 2007ABRXNoNo► Subscribe► Subscribe
Invagen Pharms
GEMFIBROZIL
gemfibrozil
TABLET;ORAL077836-001Jul 27, 2006ABRXNoNo► Subscribe► Subscribe
Cadila Pharms Ltd
GEMFIBROZIL
gemfibrozil
TABLET;ORAL203266-001Jun 17, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: gemfibrozil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms
LOPID
gemfibrozil
CAPSULE;ORAL018422-001Approved Prior to Jan 1, 19823,674,836► Subscribe
Pfizer Pharms
LOPID
gemfibrozil
CAPSULE;ORAL018422-002Approved Prior to Jan 1, 19823,674,836► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
AstraZeneca
Cerilliant
US Army
Citi
Chinese Patent Office
Chubb
Covington
Queensland Health
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot